期刊文献+

B7-H4对宫颈癌患者外周血活化T细胞增殖、凋亡和分泌细胞因子的影响 被引量:6

Influence of B7-H4 on cell proliferation,apoptosis and cytokine secretion of peripheral blood activated T cells in cervical cancer patients
下载PDF
导出
摘要 目的观察重组人B7-H4蛋白对宫颈癌患者外周血T细胞增殖周期、凋亡及分泌细胞因子的影响。方法 B7-H4分别与15例宫颈癌患者外周血活化淋巴细胞混合培养48h后,采用流式细胞术分析T细胞增殖、细胞周期、凋亡及各亚群T细胞的变化,酶联免疫吸附试验(ELISA)芯片检测培养上清液细胞因子含量。结果宫颈癌患者外周血T细胞与B7-H4混合培养48h后,G1、G2和S期的T细胞分别占90.59%、8.55%和0.87%,空白对照组T细胞各期占92.83%、6.09%和1.13%;B7-H4组CD4+T和CD8+T细胞的Ki67阳性率分别为2.13%±0.13%和1.03%±1.33%,空白对照组为2.74%±0.98%和1.71%±1.32%。B7-H4组较空白对照组CD8+T和CD4+T细胞占T细胞的比例下降,但CD4+T/CD8+T比值增高,CD4+CD25+Foxp3+T细胞增多;B7-H4组混合培养上清液中TGF-β1含量为(259.25±32.78)pg/mL,空白对照组为(202.75±20.17)pg/mL。B7-H4对宫颈癌患者外周血活化T细胞凋亡无明显影响。结论 B7-H4使宫颈癌患者外周血活化T细胞被阻滞于G2期,S期细胞明显减少;B7-H4抑制CD4+T和CD8+T细胞增殖,但对Foxp3+T细胞增殖和分泌TGF-β1可能有促进作用;B7-H4对T细胞凋亡无明显影响。B7-H4在抑制宫颈癌抗肿瘤细胞免疫中发挥作用,它可能成为宫颈癌免疫治疗的潜在靶点。 Objective To observe the in vitro influence of recombinant human B7-H4 protein on the cell proliferation cycle,apoptosis and cytokine secretion of peripheral blood activated T lymphocytes in cervical cancer patients.Methods After 48 hcoculture of peripheral blood T lymphocytes in 15 cases of cervical cancer with B7-H4 48 h,T lymphocytes′cell proliferation cycle,apoptosis and T lymphocytes subtypes changes were detected by FCM;the cytokines concentration in the culture supernatant was tested by ELISA array.Results After 48hco-culture of peripheral blood T lymphocytes with B7-H4 48 hs,G1,G2 and S phase of T cells accounted for 90.59%,8.55%and 0.87%respectively,which of the blank group were 92.83%,6.09%and 1.13%respectively;the Ki67 positive rates of CD4+T and CD8+T cells in the B7-H4 group were 2.13%±0.13% and 1.03%±1.33% respectively,which of the blank group were 2.74% ±0.98% and 1.71% ±1.32% respectively;the proportion of CD4+T and CD8+T cells accounting for T cells in the B7-H4 group was decreased compared with the blank group,but the ratio of CD4+T/CD8+T and the proportion of CD4+CD25+Foxp3+T cells were increased,in addition,the TGF-β1secretion;concentration in the co-culture supernatant in the B7-H4 group was(259.25±32.78)pg/mL,which was higher than(202.75±20.17)pg/mL in the blank group.B7-H4 had no significant influence on the peripheral blood activated T cells apoptosis.Conclusion B7-H4 block the peripheral blood activated T cells at G2 phase,the S phase cells are obviously decreased;B7-H4 inhibits the cellular proliferation of CD4+T and CD8+cells,but may have the promoting effect on Foxp3+T proliferation and TGF-β1secretion;B7-H4 has no significant influence on T cell apoptosis.B7-H4 plays a role in depressing anti-tumor T cell immune response of cervical cancer and may become a potential target of cervical cancer immunotherapy.
出处 《重庆医学》 CAS 北大核心 2015年第26期3628-3630,3633,共4页 Chongqing medicine
基金 重庆市自然科学基金(CSTC2009BB5268)
关键词 T细胞周期 宫颈肿瘤 Foxp3+ CD4+ CD8+ cell cycle cervical neoplasm Foxp3 + CD4+ CD8+
  • 相关文献

参考文献17

  • 1Park GB,Song H,Kim YS et al. Cell cycle arrest induced by engagement of B7-H4 on Epstein Barrvirus-positive B- cell lymphoma cell lines[J]. Immunology, 2009,28 (3) : 360-368.
  • 2Caigan Du, Yuzhou Wang, et al. The immunoreguIatory mechanisms of carcinoma for its survival and development [J].J Exp &. Clin Cancer Res,2011,30:12.
  • 3He C,Qiao H,Jiang H,et al. The inhibitory role of B7 H4 in antitumor immunity., association with cancer pro gression and survival [J]. Clin Dev Immunol, 2011, 695834. doi: 10. 1155/2011/695834.
  • 4王婷婷,徐曼,耿卫朴,黄文炼,陈瑜.B7-H4在人子宫颈癌的表达及其与肿瘤内浸润T细胞亚群的相关性研究[J].中国免疫学杂志,2012,28(9):812-816. 被引量:8
  • 5Park GB,Song H,Kim YS,et al. Cell cycle arrest induced By engagement of BT-H4 on Epstein Barr virus positive Bcell lymphoma cell lines [J].Immunology, 2009, 128 (3) :360-368.
  • 6Chen G, Emens LA. Chemoimmunotherapy: reengineering tumor immunity[J]. Cancer Immunol Immunother, 2013, 62(2) :203-216.
  • 7Heiber JF,Geiger TL. Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during im- munopathological conditions[J]. Cell Immunol, 2012,279 (1):60- 65.
  • 8Kosmaczewska A,Ciszak L,Potoczek S,et al. The significance of Treg cells in defective tumor im- munity[J]. Arch Immunol Ther Exp, 2008,56 (3) : 181- 191.
  • 9陈欣然,王玲,韩利霞,周凯旋,刘莉,纪晓花,单保恩.共刺激分子B7-H4在小鼠食管癌前病变进展中脾淋巴细胞表面的表达[J].肿瘤,2014,34(11):1010-1015. 被引量:2
  • 10邓敏端,李建平,区海.宫颈癌前病变与宫颈鳞癌组织中Foxp3的表达及临床意义[J].中国妇产科临床杂志,2011,12(5):338-341. 被引量:4

二级参考文献67

  • 1章圣辉,韩义香,吴建波,胡晓霞.子宫颈癌患者外周血CD_4^+ CD_(25)^+CD_(127)^(lo/-)调节性T淋巴细胞的含量及肿瘤免疫水平检测[J].中华妇产科杂志,2007,42(6):419-420. 被引量:12
  • 2Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity [J]. Immunit, 2003,18 (6):849- 861.
  • 3Kryczek I, Wei S, Zou L, et al. Cutting edge : induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells[J]. J Immunol, 2006, 177(1): 40-44.
  • 4Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 [J]. Nat I mmunol, 2005, 6 (4) : 331-337.
  • 5Reiser H, Stadecker MJ. Co-stimulatory B7 molecules in the pathogenesis of infection and autoimmune disease [J]. N Engl J Mel, 1996, 335(18): 1369-1377.
  • 6Choi IH, Zhu G, Sica GL, et al. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family [J]. J Immunol, 2003, 171 (9):4650-4654.
  • 7Bach JF. Regulatory T cells under scrutiny [J]. Nat Rev I mmunol, 2003, 3(3): 189-198.
  • 8Von Boehmer H. Mechanisms of suppression by suppress or T cells [J]. Nat I mmunol, 2005, 6(4) : 338-344.
  • 9Kiniwa Y, Miyahara Y, Wang HY, et al. CD8+Foxp3+ regulatory T cells mediate imuno suppression in prostate cancer [J]. Clin Cancer Res, 2007, 13 (23) : 6947-6958.
  • 10Rebecca P, Michael J, Justin S,et aI.Tumor infiltrating FOXP3+regulatory T-cells are assoeiated with recurrence in pathologic stage I NSCLC patients[J]. Cancer, 2006, 107:2866-2872.

共引文献13

同被引文献34

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部